We have initiated a characterization of the c&acting regulatory elements of the murine low-affinity NGF receptor (~75~~9 gene. Despite studies in cultured cells that suggest the ~75~~~~ promoter is constitutive, a detailed analysis of this promoter in five lines of transgenic mice demonstrated a high degree of cell-type specificity: 8.4 kb of 5' flanking sequence directs expression of a /acZ reporter to retinal and CNS neurons normally expressing ~75~~~~. A transgene with 470 bp of 5' flanking sequence is also expressed in the CNS, but its regulation is aberrant, with a loss of basal forebrain expression.
In non-neural tissues, both transgenes were expressed only in the testis, kidney, anterior pituitary, and pancreatic islets; with the exception of the renal pattern of expression, transgene activity was confined to appropriate cells within these tissues. In contrast, although expression of both transgenes was prominent in adrenal medulla and gastrointestinal myenteric neurons, neither construct was active in several sensory or sympathetic ganglia that strongly express the endogenous ~75~~~~ gene, indicating that genetic elements necessary for expression in these neurons are not present in these promoter sequences.
In addition, neither transgene was activated in Schwann cells during Wallerian degeneration of sciatic nerve. We conclude that regulation of the p75NGFR gene is complex, with the first 470 bp of 5' flanking sequence sufficient for expression in enteric and CNS neurons and additional elements within the first 8.4 kb of 5' flanking sequence required for restriction to appropriate CNS neurons. Further regulatory elements are possibly required for expression in at least some sensory and sympathetic neurons in the PNS and in Schwann cells. To iden-tify potential regulatory elements in the 470 bp of 5' flanking sequence from the smaller transgene, we compared the sequences of equivalent regions from the mouse, rat, and human ~75~~~~ genes. This "phylogenetic footprint" identified conserved motifs potentially important for the regulation of this gene in the CNS.
[Key words: low-affinity NGF receptor, gene regulation, transgenic mice, neurotrophins, developmental expression, IacZ] During development, many more neurons are produced than will survive to form the mature nervous system. According to the neurotrophic hypothesis, developing neurons compete for a limited quantity of target-derived neurotrophic factors and only neurons that establish connections with an appropriate target cell avoid programmed cell death. The first neurotrophic molecule identified was nerve growth factor (NGF; Levi-Montalcini, 1987) an important regulatory molecule in the developing PNS. In the PNS, NGF supports the survival of sympathetic (Thoenen and Barde, 1980 ) and a subset of neural crest-derived sensory (Goedert et al., 1984) neurons during critical developmental periods and may influence the differentiation of these same cells (Macdonnell et al., 1977; Otten et al., 1977; Max et al., 1978; Thoenen and Barde, 1980; Gage et al., I99 I ) . NGF also affects the development and differentiation of several neuronal populations in the CNS (Mobley et al., 1985; Bothwell, 199la) , including notably the intrinsic (Mobley et al., 1985) and projection (Gnahn et al., 1983; Hefti, 1986; Williams et al., 1986) cholinergic neurons of the mammalian striatum and basal forebrain, respectively. NGF belongs to a family of neurotrophins (neuronal survival and differentiation factors) that includes brainderived neurotrophic factor (BDNF; Leibrock et al., 1989) neurotrophin-3 (NT-3; Hohn et al., 1990; Maisonpierre et al., 1990; Rosenthal et al., 1990) , and neurotrophin-4/S (NT-4/5; Hallbook et al., 1991; Berkemeier et al., 1992) . Considerable evidence suggests that these other factors promote the survival and differentiation of distinct subpopulations of neurons in a fashion similar to NGF (Barde et al., 1982; Lindsay and Rohrer, 1985; Davies et al., 1986; Hofer and Barde, 1988; Lax et al., 1988; Maisonpierre et al., 1990; Rosenthal et al., 1990) . Two classes of NGF receptor with low (K,, = IO ') M) and high (K,, = IO 'I M) affinity have been identified (Sutter et al., 1979; Landreth and Shooter, 1980 ; Schecter and Bothwell, I98 I ). The biological actions of NGF are believed to be primarily mediated by the high-affinity receptor (Bothwell, 1991 b; Meakin and Shooter, 1992) , a 135-145 kDa integral membrane glycoprotein (Hosang and Shooter, 198.5; Radeke and Feinstein, 199 I) with tyrosine kinase activity (Kaplan et al., 1991 b) , which is the product of the trk proto-oncogene (Kaplan et al., 1991a; Klein et al., 1991) . The role played by the low-affinity receptor, a 75-80 kDa integral membrane glycoprotein (~75~(+~), is less clear (Rodriguez-Tebar et al., 1990; Hempstead et al., 1991; Bothwell, I99 I b; Kaplan et al., 1991a, b; Klein et al., 1991; Lee et al., 1992) , as this receptor binds all known neurotrophins with similar affinities (Rodriguez-Tebar et al., 1990; Squint0 et al., 199 I) and may not be expressed by some NGF-responsive neuronal and non-neuronal cells (Holtzman et al., 1992; Pryor et al., 1992) . In at least some cell types, however, interaction between ~75~"~'~ and trk may be necessary to mediate NGF's effects (Hempstead et al., 1991; Lee et al., 1992; Meakin and Shooter, 1992) . Alternatively, ~75~"~" may have specialized functions distinct from trk; notably, recent work suggests that P75Y"'K may promote neuronal apoptosis (Rabizadeh et al., 1993) . Investigations into these disparate possibilities could be facilitated by identifying the genetic elements responsible for regulation of this gene during development and adulthood and using this information to manipulate the expressing cell types.
The human Johnson et al., 1986) , rat (Radeke et al., 1987) , and chicken (Large et al., 1989; Heuer et al., 1990 ) low-affinity NGF receptor genes have been characterized. Although this has provided useful information on the structure of the protein, the regulation of this locus remains poorly understood (Sehgal et al., 1988; Patil et al., 1990) . Previous studies have been interpreted as indicating that the 3 kb of 5' flanking sequence adjacent to the transcription initiation site of the human P75""i+ gene contains a constitutive promoter incapable of directing cell-type-restricted expression in cultured cells (Sehgal et al., 1988; Patil et al., 1990) . However, a cosmid containing 8 kb of 5' flanking sequence, the entire NGF receptor gene and 7.5 kb of 3' flanking sequence was appropriately regulated in transgenic mice (Patil et al., 1990) . To resolve these apparently contradictory results and identify relevant regulatory sequences, we initiated a characterization of the regulatory elements of the mouse ~75""~~ gene. In this article we present an analysis of five lines of transgenic mice in which a /acZ reporter gene is driven by either an extensive region of 5' flanking sequence (8.4 kb) expected to perform all genetic functions or a presumptive minimal promoter (470 bp). Contrary to the results obtained in cultured cells, 8.4 kb of 5' flanking sequence directs spatially correct transgene expression in the retina, CNS, enteric neurons, adrenal medulla, and several non-neural tissues. A transgene with 470 bp of 5' flanking sequence also directs expression in CNS neurons, although in an aberrant pattern. Neither construct, however, produces transgene expression in several sensory or sympathetic ganglia that strongly express the endogenous P75N"F'K gene nor are they activated in Schwann cells during Wallerian degeneration of the sciatic nerve. We conclude that regulation of the ~75~~~~ gene is complex, with distinct elements necessary for expression in enteric and CNS neurons and additional elements required for expression in at least some sensory and sympathetic neurons in the PNS and in Schwann cells. Radeke et al., 1987) . This probe was "P-labeled by the random oligonucleotide priming method (Feinberg and Vogelstein, 1984) and hvbridized to duolicate tilter lifts of 5 X IO' plaques from a AFIX ( 1979) . DNA fragments were diluted to 2.5 ng/p,I in 5 mM Tris (pH 7.5)/0.25 mM EDTA/S mM NaCI.
DNA was microinjected into the male pronuclei of fertilized eggs from F, hvbrid mice (CS7BL/6 X B6C3H) as described by Hogan et al. (1986) . Oocytes surviving microinjection were implanted inio the oviducts of pseudopregnant Swiss-Webster foster mothers following established protocol (Hogan et al., 1986) . Transgenic founders were identified by polymerase chain reaction using the triple primer system of Zack et al. (1991) 
Results
Earlier work (Sehgal et al., 1988; Patil et al., 1990 ) suggested that regulatory elements directing cell-type-specific expression might be located 3-8 kb upstream of the transcription initiation site of the human ~75~';~~ gene. To identify potential regulatory elements within comparable regions of the mouse ~75~"~~ gene, lambda clones spanning I4 kb of 5' flanking sequence and the first exon were isolated and characterized (see Materials and Methods for details). A deletion series with 8.4 kb to 235 bp of 5' flanking sequence driving a luciferase reporter was constructed and introduced into p75NC't.K -expressing neuronal (PC I2 pheochromocytoma) and glial (JS I schwannoma) cell lines and three nonexpressing cell lines (NIH 3T3 fibroblasts, K5h2 erythroleukemia cells, PEER T cell lymphoma cells). In agreement with previous work (Sehgal et al., 1988; Patil et al., 1990) , we found high levels of reporter expression in all cell lines except PEER cells; expression was not appropriately cell-type restricted even when extensive portions of 5' flanking sequence were included (data not shown).
Although our initial experiments suggested that the promoter regions we had tested contained only a constitutive promoter, we were aware of instances in which promoters that were inappropriately expressed in cultured cells were properly regulated when introduced into the germline of mice (Dente et al., 1988; Zimmerman et al., 1990) . We therefore decided to examine the regulatory capabilities of these sequences in transgenic mice. To compare the regulation conferred by an extensive portion of 5' flanking sequence (X.4 kb) to that directed by a presumptive minimal promoter (470 bp), two p75N';~1~-/ucZ fusion genes were constructed that contained either 8.4 kb or 470 bp 5' of the ~75~'+~ transcription start (Patil et al., 1990) fused to the E. coli 1ucZ gene in placF (Zack et al., 1991 ; see Materials and Methods for details). These plasmids, known as p8.4MNRlacZ and p470MNR&Z, respectively, were used to produce transgenic mice. Four 8.4MNRlucZ
and nine 470MNRZucZ founders were identified and back-crossed to wild-type mates to produce F, offspring. Analyses of transgene activity by histochemical stains with X-gal or a monoclonal antibody directed against E. coli P-galactosidase were performed on 4-week-to 4-month-old transgenic mice and nontransgenic littermates from F, and sub- Table I ); these findings are consistent with the results of several previous immunohistochemical mapping studies Yan and Johnson, 1989 ).
Prominent ~75 N~;"K immunoreactivity has been found in multiple locations in the brain including the olfactory bulbs Yan and Johnson, l989) , basal forebrain cholinergic nuclei Springer et al., 1987; Yan and Johnson, l989) , some hypothalamic nuclei (Yan and Johnson, 1989; Pioro and Cuello, 1990a) , and the cerebellum Yan and Johnson, l989) , with lesser degrees of staining found in other structures such as the cortex (Koh and Loy, 1989; Pioro and Cuello, 199Oa) , striatum (Koh et al., l989) , and hippocampus (Yan and Johnson, 1989; Pioro and Cuello, 1990a) . Prior in situ hybridization studies demonstrated expression of the ~75~"~~ gene to be somewhat more restricted (Koh et al., l989) , suggesting that much (although not all) of the immunoreactivity in areas such as the olfactory bulbs, neocortex, and striatum is produced by projections from p7S"'+K-expressing neurons. To determine how closely the pattern of transgene expression in our five transgenic lines recapitulated the transcription of the endogenous gene, serial sections through the brains of transgenic mice were prepared and stained for 1acZ activity. Transgene expression was thoroughly mapped in 8.4MNRlacZ line 2 and 470MNRlacZ line I I mice, and areas found to be positive in these mice were then examined in the remaining three lines. We concentrated our efforts on the structures of the olfactory system, telencephalon, diencephalon, and cerebellum as these areas have been most extensively studied in previous work and therefore provide the most reliable descriptions of the expression of the endogenous ~75~';~" gene. Neuronal expression in the brains of mice from the 8.4MNRlucZ
lineages was confined to specific structures. We found that, in general, the pattern of expression of the 8.4MNRlucZ transgene recapitulated that of the endogenous gene (Table I ) and was readily detectable in structures such as olfactory bulb (Fig. IC) , the basal forebrain (Fig. ID) , and spe- Figure   1 . Patterns of p75NGFr~-l~~Z transgene expression in the CNS of transgenic mice. A, typical pattern of neuronal 1ucZ activity in hippocampal region CA3 of a 470MNRlacZ transgenic mouse (line 11). In these neurons, as i? all cell types expressing the p75NC.rR1acZ transgenes, /acZ activity was detected as punctate juxtanuclear areas of blue-green staining. The amount of hippocampal staining seen with this transgene is much higher than that observed in either of the 84MNRlncZ lineages, which had only rare &Z-positive neurons m this structure. This section has been hghtly counterstained with neutral red and visualized with Nomarski optics to demonstrate neuronal morphology. B, Transgene expression in ependymal/subependymal cells in the ventral portion of the third ventricle from a 470MNRlacZ mouse (dorsal, left; ventral, right) . Similar staining was found in the lateral recesses of the lateral ventricles and m the olfactory ventricles. C, Section from the olfactory bulb of an 8.4MNRlacZ mouse. Bacterial P-galactosidase activity was detected in a subpopulation of periglomerular cells (arrows) surrounding the glomeruli (x) throughout the olfactory bulb. ql, external plexiform layer. D, LacZ expression by neurons in the vertical limb of the diagonal band of Broca (8.4MNRlacZ line 2). E, Section from the cerebellum of a 4-month-old (adult) 84MNRlacZ line 2 mouse. Although a pair of hghtly /u&positive Purkinje cells are present in thiq field (arrows), transgene activity was undetectable in most of these cells even when sertal sections through a specific area were examined. Relatively more Purkinje cells were noted to be positive in the vermis. F, Section through the cerebellum of a postnatal day 8 84MNRlucZ lme 2 pup. Consistent with previous reports of higher levels of ~75~"'~ mRNA in Purkinje cells during the first 2 postnatal weeks, transgene expression is almost universal in Purkinje cells from these younger animals. For E and F: gc, granUlar Cdl layer; IX', Purkinje cell layer; ml, molecular layer; ~111, white matter; f', fetal layer of Obersteiner. Shown is a 100 km vibratome section of the basal forebrain of an 8.4MNR-1acZ mouse histochemically stained for bacterial 1acZ activity (the juxtanuclear punctate blue stuinq) and immunohtstochemically stained with a rabbit polyclonal antibody directed against the extracellular domain of ~75~"~~ (the brown stain marking the neuronal cell body as well as adjacent neuronal processes). In the basal forebrain, as well as in other CNS regions, transgene expression colocalized with immunohistochemically detectable ~75~~~~ cific hypothalamic nuclei (Table 1) . Double-label immunohistochemistry with a mouse monoclonal antibody specific for bacterial P-galactosidase (courtesy of J. Sanes) and either a chicken (courtesy of E. M. Johnson, Jr.) or rabbit (Weskamp and Reichardt, 1991) polyclonal serum directed against p7YFR confirmed that transgene expression in the basal forebrain (Fig. 2) as well as in other CNS strucfures was localized to p75N"FRexpressing neurons. Lower levels of transgene expression were noted in other structures where staining was confined to specific subpopulations previously reported to express p7YFR (e.g., very rare small neurons in the caudate-putamen; Pioro and Cuello, 1990a) . Structures in which ~7.5~"~~ expression was believed to be primarily due to the presence of immunoreactive projections from other areas of the brain showed very little evidence of transgene activity. We did, however, note low levels of expression in some neuronal populations not previously reported to express ~75~"'~ such as the supraoptic nucleus, lateral septal nucleus (Table I) , and rare neurons in lamina V of the neocortex (see below). Although we did not map expression in the brainstem as rigorously as we did in the higher structures, we again noted expression was confined to specific nuclei (e.g., prepositus hypoglossal nucleus, interpeduncular nucleus, vestibulocochlear nucleus) known to express ~75~"~~ protein or mRNA Pioro and Cuello, 1990b) .
In addition to the basal forebrain, the Purkinje neurons of the cerebellum have been extensively studied as a site of ~75~"~~ expression. Only rare ZucZ-positive Purkinje cells were found in the cerebellum of adult (4-month-old) mice from the 8.4MNRlucZ
lines (Fig. 1E) . It is, however, well established that expression of the ~75~~~~ gene is developmentally regulated in Purkinje cells, with high levels of ~75~~'~ mRNA being found only in the first 2 postnatal weeks in the rat (Wanaka and Johnson, 1990; Friedman et al., 1991) . We therefore examined transgene activity in the cerebellum of postnatal day 8 mice from 8.4MNRlacZ line 2. Unlike the Purkinje cells of the adult, the majority of these neurons in younger mice were 1ucZ positive (Fig. 1F) ; in accordance with the in situ hybridization mapping studies of Friedman et al. (1991) , transgene expression was not seen in the external granular or other cerebellar layers. These results suggest that in the cerebellum, the 8.4MNRlucZ
trans- to specific structures in the CNS (Fig. 3A-D ). An examination Although we expected the 470MNRfucZ transgene to contain of the same structures studied in the 8.4MNRZucZ mice, howa minimal promoter capable only of directing constitutive exever, showed that the pattern of expression of the 470MNRlucZ pression, this was not the case. Expression of the 470MNRlucZ transgene differed from that of the 8.4MNRlucZ construct ( Table Figure 4 . Transgene expression in the retina. A, Section of the neural retina from an adult 8.4MNRZucZ mouse. Prominent 1acZ staining is in a subpopulation of cells in the ganglion cell layer (arrows), faint staining is also seen in scattered cells in the vitread portion of the inner nuclear layer (arrowheads). B, Section of the neural retina from an adult 470MNRlacZ line 6 mouse. The distribution of transgene expression in these mice, although more intense, was identical to that seen in 8.4MNRZucZ lineages. Arrows. transgene expression in ganglion cell layer; arrowheads, 1acZ activity in the inner nuclear layer. For A and B: gc, ganglion cell layer; ipZ, inner plexiform layer; id, inner nuclear layer; opZ, outer plexiform layer; onl, outer nuclear layer; pr, photoreceptors (rods and cones). 1). Particularly notable was a lack of transgene activity in regions of the basal forebrain. In addition, ZucZ activity in the neocortex and hippocampus of the 470MNRZacZ mice was much more prominent than that seen in 8.4MNRlacZ
mice (compare Fig. 3E,F) . Although regulatory elements capable of directing appropriate CNS expression must be present in the first 470 bp of the mouse p7YGFR promoter, their activity is apparently modified by additional regulatory elements contained within the 8.4MNRZucZ transgene and upstream of the first 470 bp of 5' flanking sequence.
We next examined the eyes of transgenic animals to determine whether transgene expression in the neural retina recapitulated that of the endogenous gene. The retinas of mice from both 8. 4MNRlacZ and 470MNRlacZ lineages contained readily detectable subpopulations of lucZ-expressing neurons in the ganglion cell layer (Fig. 4A,B , arrows) and a lesser degree of histochemical staining of some cells within the vitread side of the inner nuclear layer (Fig. 4A,B, arrowheads) ; no 1ucZ activity was de- (Carmignoto et al., 1991) and the somata of these cells are located in the inner nuclear layer (Drager et al., 1984) . It therefore seems likely that the lucZ-positive cells seen in this layer are Muller glia. This overall pattern of retinal expression is consistent with that reported by Carmignoto et al. (1991) in the adult rat retina, indicating that the first 470 bp of 5' flanking sequence is sufficient to direct spatially correct expression in the neural retina.
Transgene expression in the PNS
The sensory and sympathetic ganglia of the PNS are classic sites of NGF action (Thoenen and Barde, 1980; Goedert et al., 1984) and expression of ~75~~'~ has been described in numerous neurons in these structures (reviewed in Bothwell, 1991a) , including some that are apparently unresponsive to NGF (Loeb et al., 1992) . We found, however, that neither transgene was expressed in many sensory [cervical and lumbar dorsal root ganglia (DRG), nodose and trigeminal ganglia] or sympathetic [superior cervical (KG), superior mesenteric (SMG), and coeliac ganglia] neurons of the PNS (Table 2 , Fig. 5A-C) ; the single exception was the adrenal medulla, which was intensely positive in all five lines (Fig. SD) .
To confirm the lack of transgene expression, we analyzed serial 8 pm sections through lumbar DRG from our transgenic mice. We found only rare (one to six neurons/ganglion) lacZpositive neurons in DRG from both 8.4MNRlacZ and 470MNRlucZ lineages (Fig. 5C ). In rats, 75-80% of DRG neurons have been found to express ~75~6~~ mRNA (Carroll et al., 1992) and thus it seems apparent that the number of transgeneexpressing neurons observed in the DRG of these mice falls far below the expected number. Although similar systematic analyses of the number of p75NGFR-expressing neurons in the other ganglia examined in this study have not been performed, multiple neurons expressing ~75~~"~ mRNA can be demonstrated in single sections of the superior cervical, superior mesenteric, and coeliac ganglia (M. L. Miller and S. L. Carroll, unpublished observations). It therefore seems likely that only a few of the p75NGFR-expressing neurons in these ganglia express either of the transgenes.
Although we observed only minimal 1acZ activity in sensory and sympathetic ganglia, a subpopulation of myenteric neurons throughout the digestive system were intensely 1acZ positive in both 8.4MNRlacZ
( Fig. 5 .E) and 470MNRZacZ ( Fig. 5F ) lineages. We conclude that regulation of the ~75~6~ locus in myenteric neurons and the adrenal medulla uses elements distinct from those utilized by most PNS sensory and sympathetic neu- Figure 5 . Transgene expression in the PNS. A, Section of the superior cervical ganglion of an adult 8.4MNRlacZ mouse. LacZ activity is virtually undetectable. B, Section through the trigeminal ganglion from an adult 8.4MNRZucZ mouse. Again, no transgene expression is seen. C, Section of a lumbar dorsal root ganglion from an adult 8.4MNRlacZ line 2 mouse. An extremely rare lightly staining neuron is indicated by an arrow. D, Section of adrenal gland from a 470MNRlucZ line 11 mouse. Extensive 1ucZ activity was found in the adrenal medulla. E, Transgene expression in myenteric neurons in the colon of an 8.4MNRlacZ line 2 mouse (arrows).
LacZ activity was also found in myenteric neurons from the esophagus, stomach, duodenum, jejunum, and ileum of this line. F, Transgene expression in myenteric neurons (arrow) in the ileum from a 47OMNRZucZ line 11 animal. The pattern of expression in this line was virtually identical to that seen in the 8.4MNRZucZ lines.
rons and that these elements are contained in the first 470 bp of 5' flanking sequence.
Transgene expression in non-neural tissues To establish whether the p7SNGFR transgenes were appropriately regulated outside of the nervous system, we examined their expression in a variety of non-neural tissues (see Table 3 for complete listing). Expression was detected only in the testes, kidney, pancreas, and pituitary. The adult testis normally expresses high levels of p75NGFR mRNA (Ayer-Lievre et al., 1988) , which is primarily found in Sertoli cells during specific stages of spermatogenesis (Parvinen et al., 1992) . In concordance with these studies, we found very strong expression of both transgenes in the testes (Fig. 6A) . Expression was confined to a subset of cells within the seminiferous tubules and examination of semithin plastic sections of testis stained for P-galactosidase activity showed these cells to be morphologically consistent with Sertoli cells (data not shown); we could not, however, rule out some expression by immature spermatocytic forms. These results indicate that both transgenes are appropriately regulated in testes and that the relevant regulatory elements are contained within the first 470 bp of 5' flanking sequence.
In situ hybridization for ~75~"~~ mRNA shows prominent expression of this transcript in the developing nephrons of the embryonic kidney (Sariola et al., 199 I ; Wheeler and Bothwell, 1992) , with ~75~"~~ message being confined primarily to the mesangial cells of the glomerulus in the adult (Chesa et al., 1988) . Interestingly, our transgenic mice did not precisely mimic either the adult or embryonic pattern of expression. In all five transgenic lines examined we found very intense histochemical activity in the calyx of the kidney, a region that contains primarily the loops of Henle (Fig. 6B) . A lesser degree of staining was also present in the proximal convoluted tubule adjacent to the glomeruli (data not shown). One possible explanation for the presence of bacterial p-galactosidase in the renal calyx is that this represents enzyme that has been released from other sites in the body and taken up again during urinary filtration. This explanation seems unlikely, however, since one line (47OMNRlacZ line 6) demonstrated expression of reporter enzyme only in "stripes" of cells that presumably are clonally derived. These observations suggest, rather, that additional elements not present in our transgenes are required for appropriate restriction of p75N"'.K expression in the kidney. Alternatively, we may be detecting this pattern of renal expression due to the increased sensitivity of the IacZ reporter or because our transgene product is not subject to a form of posttranscriptional regulation that acts through elements in the native ~75"';'.~ mRNA.
We found prominent transgene expression in the pancreatic islets (Fig. 6C ) and weak to moderate 1acZ activity in anterior pituitary cells (Fig. 60) . Although expression of ~75~"~~ has not been previously described in the anterior pituitary, pancreatic islet cells respond to NGF by extending neurite-like processes (Polak et al., 1993) and express ~75~"~" (Scharfmann et al., 1994a,b) . It is currently unclear which of the pancreatic islet cell and anterior pituitary cell subpopulations express our transgenes. No differences were noted between the expression patterns of the 8.4MNRlucZ
and 470MNRlucZ transgenes, again indicating that the relevant regulatory elements are within the first 470 bp of 5' flanking sequence.
Trurwgene expression in oxotomized peripherul nerve Surgical axotomy of peripheral nerves such as the sciatic has been found to result in a 50-fold increase in ~75~"'" mRNA by 7 d postaxotomy due to increased synthesis of this transcript by Schwann cells distal to the site of injury (Taniuchi et al., 1986 (Taniuchi et al., , 1988 Heumann et al., 1987) . Axotomy of the sciatic nerve has also been found to result in the reexpression of ~75""'-~ by the spinal cord motoneurons contributing fibers to the sciatic nerve (Ernfors et al., 1989) . To determine whether the 8.4MNRlacZ transgene was similarly responsive to PNS injury, unilateral sciatic axotomies were performed on male hemizygous mice from both of the 8.4MNRIucZ
lines and transgene expression was examined I, 3, 7, and IO d postaxotomy. Serial sections through segments of nerve proximal and distal to the transection site as well as the contralateral nontransected nerve were examined. Transgene expression was undetectable in nontransected sciatic nerve (Fig. 7A) . By 3-7 d postaxotomy, 1acZ activity had become detectable in clusters of spindle-shaped cells (presumably perineural cells or tibroblasts) adjacent to the site of axotomy in both the proximal and distal nerve segments (Fig. 7B) . Unexpectedly, however, /acZ expression was undetectable in Schwann cells throughout the nerve segment distal to the site of axotomy (Fig. 7C) . In addition, no expression was identified in either the L4 and L5 DRG or lumbar motoneurons in these axotomized mice (data not shown). The ~75~';'.~ gene is also A.
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known to be expressed at high levels in Schwann cells during the first 3 postnatal weeks (Heumann et al., 1987) . At postnatal day 8, however, we found only very rare &Z-positive cells in the sciatic nerve (Fig. 70) . We conclude that our transgenes lack at least some elements required for appropriate postaxotomy and developmental regulation in Schwann ceils.
Cornprison of 5' jlunking seyurnce.s ,from the mouse, human, and chicken pwes Having established that the promoter contained within the 47OMNRlacZ transgene was sufficient for expression in the CNS, retina, adrenal medulla, and myenteric neurons, we wished to identify candidate cis-acting regulatory elements within this DNA fragment. As an initial step, the sequence of this fragment was determined. The sequence of the 82 nucleotides encoding a portion of the mRNA 5' untranslated region and 470 bp of 5' flanking seyuence from this transgene is shown in Figure 8A . The promoter of the mouse ~75""~~ gene is highly G+C rich (77% over the first I 1.5 bp; see below) and, like its human counterpart (Sehgal et al., 198X) , has neither TATA or CCAAT consensus sequences (Fig. 8A) . However, as is true for many genes that lack CCAAT and TATA boxes, several GGGCGG elements representing potential binding sites for the transcription factor SPI (Dynan and Tjian, 1983; Dynan et al., 19X6) are found within the first I I5 bp of 5' flanking sequence.
As a means of identifying additional regulatory elements within the mouse promoter, the sequence of 957 nucleotides of 5' flanking sequence from the human ~75~"~" gene was determined (see Materials and Methods and Fig. 8 legend for further details). These promoter sequences as well as the published sequence of the rat promoter (Metsis et al., 1992) were compared using both alignment (Cot-pet, 1988) and dot plot homology programs (PUSTELL matrix comparison, Intelligenetics) to produce a "phylogenetic footprint," a useful aid for the identification of potential regulatory elements. The greatest degree of homology was found between the mouse and rat ~75"';'-~ promoters (83% sequence identity over the 470 nucleotides of the mouse promoter), as would be expected from the relatively smaller evolutionary distance separating these species. Alignment with the more distantly related human promoter, however, eliminated many of the sequences conserved between rat and mouse as candidate regulatory elements. Ten elements of at least 6 bp length were conserved among all three species (Fig. 8B) . The majority of the conserved elements, including four consensus SPI binding sites, were contained within the first I 15 bp of the promoters. A second cluster of homology was identified, however, approximately 300 bp 5' of the transcription initiation site.
Discussion
In an effort to define the molecular mechanisms responsible for genetic regulation during the development and regeneration of the nervous system, we and others have begun to characterize the &s-acting regulatory elements of the low-affinity NGF receptor locus, a model gene that may be of critical importance in these processes. Initial descriptions of the transcriptional regulation of this gene were enigmatic, as up to 3 kb of 5 flanking sequence from the human gene demonstrated only constitutive activity in cultured cells (Sehgal et al., 1988) observations that were at variance with the exquisite cell-type specificity of the intact gene. It was subsequently found that a cosmid with 8 kb of 5' flanking sequence, the entire human gene, and 7.5 kb of 3' flanking sequence precisely mimicked expression of the endogenous gene, including expression in sensory and sympathetic ganglia and following sciatic axotomy (Patil et al., 1990) . We therefore hypothesized that additional regulatory elements necessary for appropriate expression are located between 3 and 8 kb upstream of the human transcription start site. After extensive analysis of comparable regions of the mouse ~75~"~~ promoter in a variety of cell lines, however, we found no evidence for cell-type specificity conferred by these additional sequences. We also cloned internal fragments of the ~75~"~~ gene (beginning in intron I and proceeding systematically through the entire gene to a point 4.5 kb 3' of the gene) upstream of the 5' flanking sequence in a 470MNRluciferase
reporter in order to identify internal enhancers or silencers. Screening of these regions for enhancers or silencers functional in JS I schwannoma, PC12 pheochromocytoma, or NIH3T3 fibroblasts was similarily unsuccessful (data not shown).
It has been noted that constructs inappropriately expressed in cell lines may be more properly regulated in transgenic mice (Dente et al., 1988; Zimmerman et al., 1990 ). We therefore designed two transgenes-one with an extensive (8.4 kb) portion of 5' flanking sequence, the other with a presumably minimal promoter (470 bp)-and introduced them into the germline of mice. Despite the apparent constitutive nature of the ~75~"~~ promoter in cultured cells, we found that these sequences demonstrated a high degree of cell-type specificity in five lines of transgenic mice. The CNS was the most prominent site of transgene expression. With some minor exceptions, expression of the 8.4MNRlacZ
transgene was confined to neurons in specific structures in the brain previously found to express ~75~"~~ including the basal forebrain, specific hypothalamic nuclei, the olfactory system, and cerebellum. Occasional structures not previously known to express ~75~';'~ (e.g., lateral septal nuclei: Pioro and Cuello, 1990a) were found to express the 8.4MNRlacZ
transgene. As these structures were consistently positive in multiple transgenic lines, it seems this discrepancy is not a result of integration site effects; instead, it may be due to the increased sensitivity of the 1acZ reporter or a requirement for restrictive transcriptional elements not present in the tested portion of 5' flanking sequence. Transcription of the 470MNRlacZ construct was also confined to subpopulations of ependymal cells and neurons. The pattern of expression of this transgene differed from that of the 8.4MNRlucZ
transgene, however, in that expression in the basal forebrain was lost. In addition, IucZ activity was much more prominent in several structures (e.g., neocortex, hippocampus) not normally expressing p75 r\i(;FK; it is not clear whether this latter finding is truly aberrant expression or is merely the result of the generally higher levels of activity of the 470MNRlacZ transgene. These findings indicate that the lirst 470 nucleotides of 5' flanking sequence from the mouse ~75~"~~ gene contains regulatory elements capable of directing transcription in the brain as well as in the neural retina and several non-neural tissues. At least in the case of the basal forebrain, additional regulatory elements farther upstream are apparently necessary.
In contrast to the results obtained in the CNS, only minimal transgene activity was detected in several sensory (dorsal root) and sympathetic (coeliac, superior mesenteric, superior cervical) ganglia of neural crest origin that are classic sites of ~75~"~~ expression. There was not, however, a general absence of transgene expression in the PNS as prominent 1acZ activity was detected in the chromaffin cells of the adrenal medulla and myenteric neurons. Regulation of our transgenes was apparently also aberrant in some peripheral neurons of non-neural crest origin as ZacZ expression was not found in the trigeminal ganglion (dual neural crest and placodal origin) or in the nodose ganglion (placodal origin). For reasons currently unclear, it seems that the P75 N~;PR locus is regulated differently in the adrenal medulla and myenteric neurons than in other PNS neurons and raises the question of whether the elements required for expression in these neurons may be similar, if not identical, to those utilized by CNS neurons. This further implies that different classes of PNS neurons regulate the expression of the ~75~"~~ gene through distinct sets of regulatory elements.
Regulation of the 8.4MNRlacZ and 470MNRlucZ transgenes was aberrant in non-neural cells of the PNS as well. Surgical transection of the sciatic nerve results in a 50-fold elevation in P75 N(;FR mRNA in Schwann cells throughout the nerve segment distal to the site of axotomy by 7 d postlesioning (Taniuchi et al., 1986 (Taniuchi et al., , 1988 Heumann et al., 1987) . Although the temporal course of activation of our transgenes was virtually identical to that of the endogenous gene, 1acZ activity was confined to a population of spindle-shaped cells at the site of injury. It is currently unclear whether this expression is in a population of cells found only at the site of injury (e.g., perineurial cells proliferating at the site of injury) or whether cells immediately adjacent to the zone of injury are subject to regulatory influences not found throughout the distal nerve segment (e.g., diffusable factors). In either instance, it seems likely that appropriate responsiveness to injury requires additional regulatory elements not present in these transgenes.
We have shown that elements contained within the 5' flanking sequence from the mouse ~75~"~~ gene, although capable of directing spatially appropriate expression in the CNS and nonneural tissues, do not appear to direct expression to appropriate sites in the PNS or to respond as expected to sciatic axotomy. If the regulatory elements of the human and mouse ~75~"~~ genes are similarly positioned, then the 8.4 kb of 5' flanking sequence from the mouse gene should have been functionally equivalent to the sequences from the human ~75~~~~ cosmid previously found to be appropriately regulated in transgenic mice (Patil et al., 1990) . Our findings suggest that additional regulatory elements are embedded within the body of the gene or in the 3' flanking sequences. In this regard, our results are reminiscent of the recent report that basal and injury-responsive transcription of the peripherin gene is dependent upon intragenic elements (Belecky-Adams et al., 1991 ). An alternative possibility that must be considered, however, is that regulation of the P75N"FR locus is not purely transcriptional and may involve posttranscriptional regulatory mechanisms such as mRNA stabilization. We have, in fact, identified several regions of unusually strong conservation in the untranslated regions of these mRNAs that may function as regulatory elements (data not shown).
In summary, we have demonstrated the ability of the mouse P75 NGFR promoter to direct expression of the bacterial IacZ gene to appropriate neuronal subpopulations in the CNS. Our findings indicate that regulation of this locus in sensory and sympathetic neurons in the PNS is accomplished through the utilization of regulatory elements at least partially distinct from those responsible for CNS transcriptional control. Although the identification of these PNS regulatory elements is likely to be technically challenging due to the large size of the murine p7SNGFR gene (35-40 kb) , their characterization is of strong interest due to the light this may shed on how distinct neuronal populations differentially regulate the same gene. It is additionally possible that the various populations of CNS neurons expressing the 8.4MNRlacZ
transgene may utilize different subsets of regulatory elements contained within this 8.4 kb of 5' flanking sequence. Our identification of candidate regulatory elements within this region should be valuable in the identification of transcription factors binding to these sequences and a comparison of differential transcription factor expression in distinct neuronal populations.
